Results 1 to 10 of about 3,048 (142)

Development and implementation of the international AIDA network spondylarthritis registry [PDF]

Frontiers in Medicine
During the last decade, spondyloarthritis (SpA) has increasingly been considered a disease at the crossroads between autoimmunity and autoinflammation.
Valeria Caggiano, Valeria Caggiano, Antonio Vitale, Antonio Vitale, Andrea Hinojosa-Azaola, Guillermo Arturo Guaracha-Basañez, Piero Ruscitti, Paola Cipriani, Samar Tharwat, Samar Tharwat, Hanan M. Elberashi, Esraa E. Othman, Alessandro Conforti, Giancarlo Gimignani, Sukran Erten, Patrizia Barone, Maissa Thabet, Jurgen Sota, Jurgen Sota, José Hernández-Rodríguez, Verónica Gómez-Caverzaschi, Gaafar Ragab, Gaafar Ragab, Amina Maher, Ezgi Deniz Batu, Perla Ayumi Kawakami-Campos, Jiram Torres-Ruiz, Carla Gaggiano, Carla Gaggiano, Abdurrahman Tufan, Hamit Kucuk, Henrique A. Mayrink Giardini, Guiga Ahmed, Mehmet Akif Eksin, Lampros Fotis, Azadeh Shariat Panahi, Stefano Gentileschi, Stefano Gentileschi, Ibrahim A. Almaghlouth, Ibrahim A. Almaghlouth, Petros P. Sfikakis, George E. Fragoulis, Costanza Monterosso, Daniela Opris-Belinski, Soad Hashad, Nunzia Di Meglio, Nunzia Di Meglio, Cristian Sica, Cristian Sica, Bahar Özdemir Ulusoy, Alejandra de-la-Torre, Ewa Wiesik-Szewczyk, Katarzyna Rybak, Alberto Balistreri, Alberto Balistreri, Claudia Fabiani, Claudia Fabiani, Maria Antonietta Mazzei, Maria Antonietta Mazzei, Bruno Frediani, Bruno Frediani, Luca Cantarini, Luca Cantarini   +62 more
doaj   +2 more sources

Real world efficacy safety and drug survival of secukinumab over 6 years at the largest biological center in Poland [PDF]

Scientific Reports
Advances in biologic and targeted synthetic DMARDs have expanded treatment options for spondylarthritis. Despite improvements with TNF inhibitors, many patients remain refractory.
Anna Felis-Giemza, Małgorzata Stasiek, Karolina Palej, Marta Wysmołek-Sołtysik, Marta Łosoś, Sandra Stańczyk, Joanna Werońska-Tatara, Jakub Wroński   +7 more
doaj   +2 more sources

Effectiveness rehabilitative therapy and Pridinol Mesylate in low back pain [PDF]

Frontiers in Medicine
BackgroundSpondylarthritis is a degenerative disease involving the intervertebral disc, vertebral bodies, and adjacent soft tissues. Treatment aims to slow disease progression and manage symptoms through an interdisciplinary approach.
Lorenza Lauricella, Noemi Calabrese, Dalila Scaturro, Domenico Migliorino, Michele Vecchio, Giulia Letizia Mauro   +5 more
doaj   +2 more sources

Expanding the Genetic Framework: Insights into Non-HLA-B27 Contributions to Axial Spondylarthritis [PDF]

Medicina
Background and Objectives: Spondylarthritis is a complex group of inflammatory diseases closely associated with the HLA-B27 antigen. However, the role of non-HLA-B27 alleles in the disease’s pathogenesis has gained significant scholarly attention in ...
Ruxandra-Elena Nagit, Ioana Bratoiu, Corina Cianga, Mariana Pavel-Tanasa, Elena Rezus, Petru Cianga   +5 more
doaj   +2 more sources

Reactive arthritis [PDF]

European Journal of Case Reports in Internal Medicine
Reactive arthritis is a form of seronegative spondylarthritis that presents following an infection, with clear associations to specific microorganisms. It is a rare entity and typically affects young adults.
Carolina António Santos, Frederico Trigueiros, Inês Machado Leite   +2 more
doaj   +2 more sources

Metabolomics in spondylarthritis

BMC Rheumatology
Background and aim Spondyloarthritides (SpA) are common entities of the inflammatory rheumatic type. There are still 3 relevant problems in everyday clinical practice: early disease detection, cardiovascular risk assessment, and less so, disease activity
Susann Patschan, Constantin Remus, Inga Claus, Meike Hoffmeister, Oliver Ritter, Daniel Patschan   +5 more
doaj   +2 more sources

THE EVOLUTION OF SPONDYLARTHRITIS – A THERAPEUTIC CHALLENGE [PDF]

Romanian Journal of Rheumatology, 2017
We are presenting the case of a 36 years old male diagnosed at the age of 20 with reactive arthritis and at 27 years with ankylosing spondylitis. During the course of the disease, the patient followed treatment with non-steroidal anti-inflammatory drugs,
Cristina Radu, Maria Laura Groseanu, Ruxandra Ionescu   +2 more
doaj   +1 more source

General Characteristics of the Patients Diagnosed with Enteropathic Arthritis (ENA) whose Treatment Have Been Performed With Biological Agents

Turkish Journal of Internal Medicine, 2021
Introduction: Spondylarthritis (SpA) comprises multiple divergent forms of inflammatory arthritis. ENA ranks in SpA group. It is aimed to present the features of 33 ENA cases which have been being monitored in our clinic, in this study.
Nihal Lermi, Yavuz Pehlivan
doaj   +1 more source

Foot-Worn Inertial Sensors Are Reliable to Assess Spatiotemporal Gait Parameters in Axial Spondyloarthritis under Single and Dual Task Walking in Axial Spondyloarthritis

Sensors, 2020
The aim of this study was (1) to evaluate the relative and absolute reliability of gait parameters during walking in single- and dual-task conditions in patients with axial spondyloarthritis (axSpA), (2) to evaluate the absolute and relative reliability ...
Julie Soulard, Jacques Vaillant, Romain Balaguier, Athan Baillet, Philippe Gaudin, Nicolas Vuillerme   +5 more
doaj   +1 more source

Lower urinary tract symptoms in rheumatoid arthritis and spondyloarthritis male patients versus controls

Romanian Journal of Internal Medicine, 2021
Background. We aimed to evaluate the severity of lower urinary tract symptoms (LUTS) in rheumatoid arthritis (RA) and spondyloarthritis (SpA) male patient versus control, then to determine the relation of LUTS with rheumatic diseases (RD) characteristics
Leila Rouached, Alia Fazaa, Khereddine Mourad Dali, Ben Rhouma Sami, Saoussen Miladi, Kmar Ouenniche, Leila Souabni, Selma Kassab, Selma Chekili, Kawther Ben Abdelghani, Yassine Nouira, Ahmed Laatar   +11 more
doaj   +1 more source